Jeffers, L., Santarsieri, A., Osborne, W., Chevillon, F., Vely, A., Bhartia, V., Collins, G., Barrett, A., Marzolini, M., George, L., Bhuller, K., Burton, C., Ogome, S., Shah, N., Iyengar, S., McDonald, L., Radhakrishnan, V., Jayakody, H., Chernucha, E., Culligan, D., Mathur, A., McKay, P., Jamil, F., Phillips, E. (2025). Relapsed/Refractory Hodgkin lymphoma after first-line escalated beacopdac: Adverse outcomes are overcome by use of second-line targeted therapy - an international real-world analysis. Blood. https://doi.org/10.1182/blood-2025-3623